Pharmaceutical industry says HSE not funding cost-effective ...
News | 18 June 2012
The organisation representing the pharmaceutical industry has claimed that patients are not getting access to new medicines.
Click on the link to read the full article at RTE.ie
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
